Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors

References

• MendellJRShillingCLeslieNDEvidence-based path to newborn screening for Duchenne muscular dystrophyAnn Neurol201271330431322451200
   PubMed Web of Science ®Google Scholar
• HoffmanEPBrownRHJrKunkelLMDystrophin: the protein product of the Duchenne muscular dystrophy locusCell19875169199283319190
   PubMed Web of Science ®Google Scholar
• LjubicicVBurtMJasminBJThe therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targetsFASEB J201428254856824249639
   PubMed Web of Science ®Google Scholar
• OguraYTajrishiMMSatoSHindiSMKumarATherapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophyFront Cell Dev Biol201421125364719
   PubMed Web of Science ®Google Scholar
• CirakSArechavala-GomezaVGuglieriMExon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyLancet2011378979159560521784508
   PubMed Web of Science ®Google Scholar
• MojumdarKLiangFGiordanoCInflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2EMBO Mol Med20146111476149225312642
   PubMed Web of Science ®Google Scholar
• GiordanoCMojumdarKLiangFToll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophyHum Mol Genet20152482147216225552658
   PubMed Web of Science ®Google Scholar
• VillaltaSANguyenHXDengBGotohTTidballJGShifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophyHum Mol Genet200918348249618996917
   PubMed Web of Science ®Google Scholar
• FindlayARWeinNKaminohYClinical phenotypes as predictors of the outcome of skipping around DMD exon 45Ann Neurol201577466867425612243
   PubMed Web of Science ®Google Scholar
• KoleRKrainerARAltmanSRNA therapeutics: beyond RNA interference and antisense oligonucleotidesNat Rev2012112125140
   Google Scholar
• WoodMJGaitMJYinHRNA-targeted splice-correction therapy for neuromuscular diseaseBrain2010133Pt 495797220150322
   PubMedGoogle Scholar
• KooTWoodMJClinical trials using antisense oligonucleotides in Duchenne muscular dystrophyHum Gene Ther201324547948823521559
   PubMed Web of Science ®Google Scholar
• Aartsma-RusAFokkemaIVerschuurenJTheoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutationsHum Mutat200930329329919156838
   PubMed Web of Science ®Google Scholar
• AhimaRSParkHKConnecting myokines and metabolismEndocrinol Metab2015303235245
   Google Scholar
• BonifatiMDRuzzaGBonomettoPA multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophyMuscle Nerve20002391344134710951436
   PubMed Web of Science ®Google Scholar
• EscolarDMHacheLPClemensPRRandomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyNeurology201177544445221753160
   PubMed Web of Science ®Google Scholar
• FalzaranoMSScottonCPassarelliCFerliniADuchenne muscular dystrophy: from diagnosis to therapyMolecules20152010181681818426457695
   PubMed Web of Science ®Google Scholar
• HuizengaNAKoperJWDe LangePA polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivoJ Clin Endocrinol Metab19988311441519435432
   PubMed Web of Science ®Google Scholar
• WolthersODPedersenSShort term linear growth in asthmatic children during treatment with prednisoloneBMJ199030167441451482202451
   PubMedGoogle Scholar
• AvioliLVGlucocorticoid effects on statural growthBr J Rheumatol199332Suppl 227308495277
   PubMedGoogle Scholar
• GroundsMDShavlakadzeTGrowing muscle has different sarcolemmal properties from adult muscle: a proposal with scientific and clinical implications: reasons to reassess skeletal muscle molecular dynamics, cellular responses and suitability of experimental models of muscle disordersBioEssays201133645846821500235
   PubMed Web of Science ®Google Scholar
• RicciottiEFitzGeraldGAProstaglandins and inflammationArterioscler ThrombVasc Biol20113159861000
   PubMed Web of Science ®Google Scholar
• SerraFQuartaMCanatoMInflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugsMuscle Nerve201246577378422847332
   PubMed Web of Science ®Google Scholar
• MartinezLErmolovaNVIshikawaTOStoutDBHerschmanHRSpencerMJA reporter mouse for optical imaging of inflammation in mdx musclesSkelet Muscle201551525949789
   PubMed Web of Science ®Google Scholar
• SchaecherKGoustJMBanikNLThe effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sitesNeurochem Res20042971443145115202778
   PubMed Web of Science ®Google Scholar
• AcharyyaSVillaltaSABakkarNInterplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophyJ Clin Invest2007117488990117380205
   PubMed Web of Science ®Google Scholar
• VillaltaSARosenbergASBluestoneJAThe immune system in Duchenne muscular dystrophy: friend or foeRare Dis201531e101096626481612
   PubMedGoogle Scholar
• MillayDPGoonasekeraSASargentMAMailletMAronowBJMolkentinJDCalcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanismProc Natl Acad Sci U S A200910645190231902819864620
   PubMed Web of Science ®Google Scholar
• CooperSTMcNeilPLMembrane repair: mechanisms and pathophysiologyPhysiol Rev20159541205124026336031
   PubMed Web of Science ®Google Scholar
• ZhaoXMoloughneyJGZhangSKomazakiSWeislederNOrai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal musclePloS One2012711e4986223185465
   PubMed Web of Science ®Google Scholar
• GaillyPTRP channels in normal and dystrophic skeletal muscleCurr Opin Pharmacol201212332633422349418
   PubMed Web of Science ®Google Scholar
• GervasioOLWhiteheadNPYeungEWPhillipsWDAllenDGTRPC1 binds to caveolin-3 and is regulated by Src kinase – role in Duchenne muscular dystrophyJ Cell Sci2008121Pt 132246225518544631
   PubMed Web of Science ®Google Scholar
• IwataYKatanosakaYAraiYShigekawaMWakabayashiSDominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal modelsHum Mol Genet200918582483419050039
   PubMed Web of Science ®Google Scholar
• AoyagiKOhara-ImaizumiMNishiwakiCNakamichiYNagamatsuSInsulin/phosphoinositide 3-kinase pathway accelerates the glucose-induced first-phase insulin secretion through TrpV2 recruitment in pancreatic beta-cellsBiochem J2010432237538620854263
   PubMedGoogle Scholar
• IwataYKatanosakaYShijunZProtective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cellsBiochem Pharmacol200570574075116009351
   PubMed Web of Science ®Google Scholar
• SwiderskiKTodorovMGehrigSMTranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic miceFibrogenesis Tissue Repair201471124476069
   PubMedGoogle Scholar
• VriensJAppendinoGNiliusBPharmacology of vanilloid transient receptor potential cation channelsMol Pharmacol20097561262127919297520
   PubMed Web of Science ®Google Scholar
• BoittinFXPetermannOHirnCCa2+-independent phospholipase A2 enhances store-operated Ca2+ entry in dystrophic skeletal muscle fibersJ Cell Sci2006119Pt 183733374216926189
   PubMed Web of Science ®Google Scholar
• LindahlMBackmanEHenrikssonKGGorospeJRHoffmanEPPhospholipase A2 activity in dystrophinopathiesNeuromuscul Disord1995531931997633184
   PubMed Web of Science ®Google Scholar
• WhiteheadNPPhamCGervasioOLAllenDGN-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx miceJ Physiol200858672003201418258657
   PubMed Web of Science ®Google Scholar
• RueggUTPharmacological prospects in the treatment of Duchenne muscular dystrophyCurr Opin Neurol201326557758423995279
   PubMed Web of Science ®Google Scholar
• ItoNRueggUTKudoAMiyagoe-SuzukiYTakedaSActivation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophyNat Med201319110110623202294
   PubMed Web of Science ®Google Scholar
• IsmailHMScapozzaLRueggUTDorchiesOMDiapocynin, a dimer of the NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic musclePloS One2014910e11070825329652
   PubMed Web of Science ®Google Scholar
• MarxSOMarksARDysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseasesJ Mol Cell Cardiol20135822523123507255
   PubMed Web of Science ®Google Scholar
• AnderssonDCMeliACReikenSLeaky ryanodine receptors in beta-sarcoglycan deficient mice: a potential common defect in muscular dystrophySkelet Muscle201221922640601
   PubMedGoogle Scholar
• NetheryDCallahanLAStofanDMatteraRDiMarcoASupinskiGPLA(2) dependence of diaphragm mitochondrial formation of reactive oxygen speciesJ Appl Physiol2000891728010904037
   PubMed Web of Science ®Google Scholar
• HauserEHogerHBittnerRWidhalmKHerknerKLubecGOxyradical damage and mitochondrial enzyme activities in the mdx mouseNeuropediatrics19952652602628552217
   PubMed Web of Science ®Google Scholar
• BuyseGMVan der MierenGErbMLong-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performanceEur Heart J200930111612418784063
   PubMed Web of Science ®Google Scholar
• NakaeYHirasakaKGotoJSubcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological studyHistochem Cell Biol2008129448950118264714
   PubMed Web of Science ®Google Scholar
• DorchiesOMWagnerSVuadensOGreen tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophyAm J Physiol20062902C616C625
   PubMed Web of Science ®Google Scholar
• EvansNPCallJABassaganya-RieraJRobertsonJLGrangeRWGreen tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx miceClin Nutr201029339139819897286
   PubMed Web of Science ®Google Scholar
• HaydenMSGhoshSSignaling to NF-kappaBGenes Dev200418182195222415371334
   PubMed Web of Science ®Google Scholar
• ChenYWNagarajuKBakayMEarly onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophyNeurology200565682683416093456
   PubMed Web of Science ®Google Scholar
• PorterJDKhannaSKaminskiHJA chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx miceHum Mol Genet200211326327211823445
   PubMed Web of Science ®Google Scholar
• PorterJDMerriamAPLeahyPGongBKhannaSDissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) miceHum Mol Genet200312151813182112874102
   PubMed Web of Science ®Google Scholar
• HeierCRDamskerJMYuQVBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsEMBO Mol Med20135101569158524014378
   PubMed Web of Science ®Google Scholar
• GroundsMDTorrisiJAnti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosisFASEB J200418667668215054089
   PubMed Web of Science ®Google Scholar
• PiernoSNicoBBurdiRRole of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approachNeuropathol Appl Neurobiol200733334435917493014
   PubMed Web of Science ®Google Scholar
• HodgettsSRadleyHDaviesMGroundsMDReduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx miceNeuromuscul Disord2006169–1059160216935507
   PubMed Web of Science ®Google Scholar
• PiersATLavinTRadley-CrabbHGBakkerAJGroundsMDPinnigerGJBlockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal miceNeuromuscul Disord201121213214121055937
   PubMed Web of Science ®Google Scholar
• MiyatakeSBilanPJPillonNJKlipAContracting C2C12 myotubes release CCL2 in an NF-kappaB-dependent manner to induce monocyte chemoattractionAm J Physiol20163102E160E170
   Google Scholar
• De PaepeBCreusKKMartinJJDe BleeckerJLUpregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosisMuscle Nerve201246691792523225384
   PubMed Web of Science ®Google Scholar
• PorterJDGuoWMerriamAPPersistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscleNeuromuscul Disord200313322323512609504
   PubMed Web of Science ®Google Scholar
• MiyatakeSManabeYInagakiAMacrophage migration inhibitory factor diminishes muscle glucose transport induced by insulin and AICAR in a muscle type-dependent mannerBiochem Biophys Res Commun2014444449650124472542
   PubMed Web of Science ®Google Scholar
• ReimannJSchnellSSchwartzSKappes-HornKDodelRBacherMMacrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathiesJ Neuropathol Exp Neurol201069665466220467327
   PubMed Web of Science ®Google Scholar
• BrzoskaEKowalskiKMarkowska-ZagrajekASdf-1 (CXCL12) induces CD9 expression in stem cells engaged in muscle regenerationStem Cell Res Ther201564625890097
   PubMed Web of Science ®Google Scholar
• ChargeSBRudnickiMACellular and molecular regulation of muscle regenerationPhysiol Rev200484120923814715915
   PubMed Web of Science ®Google Scholar
• GuttridgeDCMayoMWMadridLVWangCYBaldwinASJrNF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexiaScience200028954882363236611009425
   PubMed Web of Science ®Google Scholar
• ThaloorDMillerKJGephartJMitchellPOPavlathGKSystemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injuryAm J Physiol19992772 Pt 1C320C32910444409
   PubMedGoogle Scholar
• MourkiotiFKratsiosPLueddeTTargeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regenerationJ Clin Invest2006116112945295417080195
   PubMed Web of Science ®Google Scholar
• ProtoJDTangYLuANF-kappaB inhibition reveals a novel role for HGF during skeletal muscle repairCell Death Dis20156e173025906153
   PubMed Web of Science ®Google Scholar
• ChenGYNunezGSterile inflammation: sensing and reacting to damageNat Rev20101012826837
   Google Scholar
• HathoutYMarathiRLRayavarapuSDiscovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patientsHum Mol Genet201423246458646925027324
   PubMed Web of Science ®Google Scholar
• HathoutYBrodyEClemensPRLarge-scale serum protein biomarker discovery in Duchenne muscular dystrophyProc Natl Acad Sci U S A2015112237153715826039989
   PubMed Web of Science ®Google Scholar
• PaepeBDCreusKKWeisJBleeckerJLHeat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destructionNeuromuscul Disord2012221263321855341
   PubMed Web of Science ®Google Scholar
• VidalBSerranoALTjwaMFibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathwayGenes Dev200822131747175218593877
   PubMed Web of Science ®Google Scholar
• VillaltaSARosenthalWMartinezLRegulatory T cells suppress muscle inflammation and injury in muscular dystrophySci transl Med20146258258ra142
   PubMed Web of Science ®Google Scholar
• VetroneSAMontecino-RodriguezEKudryashovaEOsteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-betaJ Clin Invest200911961583159419451692
   PubMed Web of Science ®Google Scholar
• MojumdarKGiordanoCLemaireCDivergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophyJ Pathol20162391102226800321
   PubMed Web of Science ®Google Scholar
• Henriques-PonsAYuQRayavarapuSRole of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscleHum Mol Genet201423102604261724368419
   PubMed Web of Science ®Google Scholar
• YoungCNBrutkowskiWLienCFP2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatmentJ Cell Mol Med20121651026103721794079
   PubMed Web of Science ®Google Scholar
• JiangTYeungDLienCFGoreckiDCLocalized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscleNeuromuscul Disord200515322523615725584
   PubMed Web of Science ®Google Scholar
• BuvinicSAlmarzaGBustamanteMATP released by electrical stimuli elicits calcium transients and gene expression in skeletal muscleJ Biol Chem200928450344903450519822518
   PubMed Web of Science ®Google Scholar
• YeungDZablockiKLienCFIncreased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cellsFASEB J200620661062016581969
   PubMed Web of Science ®Google Scholar
• YoungCNSinadinosALefebvreAA novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90Autophagy201511111313025700737
   PubMed Web of Science ®Google Scholar
• RawatRCohenTVAmpongBInflammasome up-regulation and activation in dysferlin-deficient skeletal muscleAm J Pathol201017662891290020413686
   PubMed Web of Science ®Google Scholar
• GazzerroEBaldassariSAsseretoSEnhancement of muscle T regulatory cells and improvement of muscular dystrophic process in mdx mice by blockade of extracellular ATP/P2X axisAm J Pathol2015185123349336026465071
   PubMed Web of Science ®Google Scholar
• PedersenBKFebbraioMAMuscles, exercise and obesity: skeletal muscle as a secretory organNat Rev201288457465
   Google Scholar
• KnudsenJGBertholdtLJoensenELassenSBHidalgoJPilegaardHSkeletal muscle interleukin-6 regulates metabolic factors in iWAT during HFD and exercise trainingObesity20152381616162426109166
   PubMed Web of Science ®Google Scholar
• RufoADel FattoreACapulliMMechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humansJ Bone Miner Res20112681891190321509823
   PubMed Web of Science ®Google Scholar
• PelosiLBerardinelliMGDe PasqualeLFunctional and morphological improvement of dystrophic muscle by interleukin 6 receptor blockadeEBioMedicine20152428529326137572
   PubMed Web of Science ®Google Scholar
• PelosiLBerardinelliMGForcinaLIncreased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx miceHum Mol Genet201524216041605326251044
   PubMed Web of Science ®Google Scholar
• KurosakaMMachidaSInterleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2/STAT3 signalling pathway through cyclin D1 targetingCell Proliferat2013464365373
   PubMed Web of Science ®Google Scholar
• KurekJBNouriSKannourakisGMurphyMAustinLLeukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscleMuscle Nerve19961910129113018808655
   PubMed Web of Science ®Google Scholar
• SerranoALBaeza-RajaBPerdigueroEJardiMMunoz-CanovesPInterleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophyCell Metabol2008713344
   PubMed Web of Science ®Google Scholar
• GabayCInterleukin-6 and chronic inflammationArthritis Res Ther20068Suppl 2S316899107
   PubMed Web of Science ®Google Scholar
• PagelCNWasgewatte WijesingheDKTaghavi EsfandouniNMackieEJOsteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscleJ Cell Commun Signal2014829510324318932
   PubMed Web of Science ®Google Scholar
• UaesoontrachoonKWasgewatte WijesingheDKMackieEJPagelCNOsteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injuryDis Model Mech20136119720522917925
   PubMed Web of Science ®Google Scholar
• KuraokaMKimuraENagataTSerum osteopontin as a novel biomarker for muscle regeneration in Duchenne muscular dystrophyAm J Pathol201618651302131226963343
   PubMed Web of Science ®Google Scholar
• PegoraroEHoffmanEPPivaLSPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophyNeurology201176321922621178099
   PubMed Web of Science ®Google Scholar
• BarfieldWLUaesoontrachoonKWuCSEccentric muscle challenge shows osteopontin polymorphism modulation of muscle damageHum Mol Genet201423154043405024626632
   PubMed Web of Science ®Google Scholar
• McPherronACLawlerAMLeeSJRegulation of skeletal muscle mass in mice by a new TGF-beta superfamily memberNature1997387662883909139826
   PubMed Web of Science ®Google Scholar
• ThomasMLangleyBBerryCMyostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferationJ Biol Chem200027551402354024310976104
   PubMed Web of Science ®Google Scholar
• ZimmersTADaviesMVKoniarisLGInduction of cachexia in mice by systemically administered myostatinScience200229655721486148812029139
   PubMed Web of Science ®Google Scholar
• AbeSSoejimaMIwanumaOExpression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophyZoolog Sci200926531532019715499
   PubMed Web of Science ®Google Scholar
• McCroskerySThomasMMaxwellLSharmaMKambadurRMyostatin negatively regulates satellite cell activation and self-renewalJ Cell Biol200316261135114712963705
   PubMed Web of Science ®Google Scholar
• LangleyBThomasMBishopASharmaMGilmourSKambadurRMyostatin inhibits myoblast differentiation by down-regulating MyoD expressionJ Biol Chem200227751498314984012244043
   PubMed Web of Science ®Google Scholar
• BogdanovichSKragTOBartonERFunctional improvement of dystrophic muscle by myostatin blockadeNature2002420691441842112459784
   PubMed Web of Science ®Google Scholar
• BogdanovichSPerkinsKJKragTOWhittemoreLAKhuranaTSMyostatin propeptide-mediated amelioration of dystrophic pathophysiologyFASEB J200519654354915791004
   PubMed Web of Science ®Google Scholar
• WagnerKRFleckensteinJLAmatoAAA phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyAnn Neurol200863556157118335515
   PubMed Web of Science ®Google Scholar
• CadenaSMTomkinsonKNMonnellTEAdministration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber typeJ Appl Physiol2010109363564220466801
   PubMed Web of Science ®Google Scholar
• LeeSJLeeYSZimmersTARegulation of muscle mass by follistatin and activinsMol Endocrinol201024101998200820810712
   PubMedGoogle Scholar
• MendellJRSahenkZMalikVA phase 1/2a follistatin gene therapy trial for Becker muscular dystrophyMol Ther201523119220125322757
   PubMed Web of Science ®Google Scholar
• BartonERMorrisLMusaroARosenthalNSweeneyHLMuscle-specific expression of insulin-like growth factor I counters muscle decline in mdx miceJ Cell Biol2002157113714811927606
   PubMed Web of Science ®Google Scholar
• PelosiLGiacintiCNardisCLocal expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokinesFASEB J20072171393140217264161
   PubMed Web of Science ®Google Scholar
• Lu-NguyenNBJarminSASalehAFPopplewellLGaitMJDicksonGCombination antisense treatment for destructive exon skipping of myostatin and open reading frame rescue of dystrophin in neonatal mdx miceMol Ther20152381341134825959011
   PubMed Web of Science ®Google Scholar
• LongCMcAnallyJRSheltonJMMireaultAABassel-DubyROlsonENPrevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNAScience201434562011184118825123483
   PubMed Web of Science ®Google Scholar